Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Pharma
Amgen, AZ's Tezspire lands ph. 3 eosinophilic esophagitis win
The eosinophilic esophagitis trial win positions the anti-TSLP biologic to potentially expand into its third inflammatory disease indication.
Angus Liu
Aug 27, 2026 10:17am
EU regulators offer post-mortem of Tavneos withdrawal decision
Aug 14, 2026 11:04am
Amgen doesn't think Repatha's sales wins will stop anytime soon
Aug 4, 2026 4:01pm
Amgen says patient data, IP stolen in cybersecurity breach
Aug 3, 2026 11:05am
Amgen joins MrBeast, Stand Up to Cancer in pediatric cancer mission
Jul 30, 2026 10:46am
Amgen submits analyses to FDA in bid for Tavneos hearing
Jul 24, 2026 10:50am
